Findings from a multinational study suggest that adding an AI-integrated platform to training masterclasses for pathologists boosts their accuracy in classifying HER2-stained breast cancer samples, particularly when it comes to pinpointing “low” and “ultralow” categories. Incorporating AI ...

Treatment with lurbinectedin (Zepzelca; Jazz Pharmaceuticals) and atezolizumab (Tecentriq; Genentech) improved overall survival (OS) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the phase III IMforte trial. Median OS among the 242 patients with ES-SCLC who received the ...